Jonathan Abram Bernstein MD
Professor of Medicine, University Cincinnati
Join to View Full Profile
4665 East Galbraith Road2nd FloorCincinnati, OH 45236
Phone+1 513-931-0775
Fax+1 513-931-0798
Dr. Bernstein is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Jonathan Bernstein is an allergist/immunologist in Cincinnati, OH and is Professor of Clinical Medicine at the University of Cincinnati College of Medicine Department of Internal Medicine, Division of Internal Medicine Division of Rheumatology, Allergy and Immunology and partner of Advanced Allergy Services,LLC and Bernstein Clinical Research Center. He received his medical degree from University of Cincinnati College of Medicine completed his IM residency at the Cleveland Clinic and Allergy fellowship at Northwestern University. He has been in practice 35 years. He is experienced in managing complex unexplained medical disorders, asthma, rhinitis., mast cell disorders, dysautonomia, PANDAS/PANS chronic urticaria, hereditary angioedema, progesterone hypersensitivity and atopic dermatitis and immunodeficiency. He has published over 540 peer reviewed articles and book chapters and is the editor of five books. He is involved in leadership roles in many professional organizations and was Past-President of the AAAAI and current Chai of the AAAAI foundation. He is the co-chair of the WAO and AIM center of excellence and chair of the UCAZrE/ACARE/ADCARE/ANACARE center of excellence.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Allergy and Immunology, 1988 - 1990
Cleveland Clinic FoundationResidency, Internal Medicine, 1985 - 1988
University of Cincinnati College of MedicineClass of 1985
Kenyon CollegeB.A., Chemistry, 1977 - 1981
Certifications & Licensure
IN State Medical License 1995 - 2027
OH State Medical License 1986 - 2027
KY State Medical License 2002 - 2026
IL State Medical License 1988 - 1990
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Top Doctor Cincinnati Magazine, 2000-2022
- Distinguished Clinician Award AAAAI, 2019
- Distinguished Clinician Award WAO, 2019
Clinical Trials
- Singulair Use in Non-Allergic Rhinitis Eosinophil Syndrome (NARES) Start of enrollment: 2006 Nov 01
- Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema Start of enrollment: 2010 May 01
- Observational Safety Study for KALBITOR (Ecallantide) in the Treatment of Acute Attacks of Hereditary Angioedema Start of enrollment: 2010 Feb 01
Publications & Presentations
PubMed
- The Diagnosis of Non-Allergic Rhinitis.Julie van Waterschoot, Laura Van Gerven, Scott Pfirrman, Justin Greiwe, Jonathan A Bernstein
Immunology and Allergy Clinics of North America. 2026-02-01 - 1 citationsEfficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-co...Emma Guttman-Yassky, Kenji Kabashima, Margitta Worm, Paula C Luna, H Chih-Ho Hong
Lancet. 2026-01-03 - Change, Career Transitions, and Retirement in Allergy-Immunology.Melinda Rathkopf, Ray S Davis, Dana V Wallace, Thomas A Fleisher, Michael E Conti
The Journal of Allergy and Clinical Immunology. in Practice. 2026-01-01
Journal Articles
- Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema AttacksJonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
- Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients with Chronic Idiopathic (Spontaneous) UrticariaJonathan A Bernstein, Michael D Tharp, Ivo Abraham, JAMA
- Correspondence and Reply ReplyJonathan Bernstein, MD, ScienceDirect
Books/Book Chapters
Lectures
- 3rd Annual North American Rhinology & Allergy Conference(NARAC)North American Rhinology & Allergy Conference(NARAC), Fajardo, Puerto Rico - 1/31/2013
Other
- Talanta. Portable method of measuring gaseous acetone concentrationsWorrall AD, Bernstein JA, Angelopoulos AP
8/1/2013 - New drug targets and future directions: EcallantideBernstein JA
http://www.futuremedicine.com
1/1/2011 - Allergic Rhinitis and Asthma: Role of Environmental DeterminantsBernstein JA
http://www.consultant.com
7/1/2006
Press Mentions
Updates on Treatment Options for Urticaria from ACAAI 2025December 3rd, 2025- Phase 3 Study in ColdU and SD to Initiate in December 2025November 6th, 2025
- Pharming Group Announces Presentations at 2025 ACAAI Annual Scientific Meeting Showcasing New Data Across Rare Disease PortfolioOctober 20th, 2025
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
